Vol 33 No. 2 PDF

Index

Subject index to volume 33
A
Accreditation Council for Graduate Medical Education,
40
Aeta
characteristics, 44
lifestyle, 42, 44
prevalence of low vision, 45
results of visual screening, 44
types and frequency of vision-related disorders, 42
visual status, 41
Ahmed glaucoma valve
complications, 17, 18
implantation, 17
rates of tube erosion, 17
role in the treatment of glaucoma, 18
Amblyopia
cause of blindness among the Aeta, 43
cause of low-vision among the Aeta, 45
Amphotericin B
treatment for candidemia, 35
Amvisc Plus
compared with DisCoVisc, 6, 8
effects on the corneal endothelium, 7
Analgesia
preemptive
in ocular surgery, 14
in pterygium surgery, 13
to reduce postoperative pain, 14
Angle-opening distance, 54
before and after LPI in eyes with NOA, 57
Anterior chamber
angle anatomy in eyes with PACS, 53
Antibiotics
long-term prophylaxis
for posttrabeculectomy patients, 69
intravitreal injection
for posterior endophthalmitis, 69
systemic
use in the treatment of bleb-related
endophthalmitis, 69
topical
use in treatment of bleb-related infections, 68
Antifibrotics
use in glaucoma filtering surgery, 68
AOD
See angle-opening distance
AP
See Amvisc Plus
Autologous scleral flap
alternative to donor scleral graft, 21
advantages, 18
compared with donor scleral graft, 17
comparison of outcomes with donor scleral graft, 21

B
Bleb infections
common organisms involved in, 68
Blebitis,
definition, 68
diagnosis of, 68
treatment with topical antibiotics, 68
Blindness
among the Aeta population, 41
arising from corneal opacities and deformities, 60
causes in developing nations, 45
causes among the Aeta, 43, 45
prevalence among the Aeta, 45
worldwide prevalence, 45

C
Candida albicans
cause of endophthalmitis, 35
Candida endogenous endophthalmitis
case of, 33
Candidemia
arising from urinary-tract infection, 35
leading to endophthalmitis, 34
risk factors for, 34
treatment of, 35
Cataract
cause of blindness among the Aeta, 43
cause of vision loss among the Aeta, 41
leading cause of blindness, 45
surgery
aims of, 10
complication of, 7
failure, common cause of, 6
Ciliary-body thickness, 54
Clindamycin
intravitreal
for treatment of juxtapapillary toxoplasmic
retinochoroiditis, 63, 64
Competency-based curriculum, 39
Conjunctival hyperemia
postoperative
treatment with triamcinolone, 24, 25
Cornea
donor
maintaining viability, 60, 61
preservation, 60
opacities, 60
Corneal edema
complication of cataract surgery, 7
Corneal endothelium
protection during cataract surgery, 7
Corneal thickness
changes during storage in Optisol GS, 61
in donor eyes stored in Optisol GS, 59
Corticosteroid
use in controlling postopertive inflammation, 23
CT
See corneal thickness

D
DES
See DRY-EYE syndrome
Dexamethasone
treatment for juxtapapillary toxoplasmic
retinochoroiditis, 63
Diclofenac
as preemptive analgesic
insufficiency, 15
for pterygium surgery, 13, 14
half-life, 15
mechanism of action, 15
DisCoVisc
compared with Amvisc Plus, 6
properties of, 7
Donor scleral graft
compared with autologous scleral flap, 17
outcomes compared with autologous scleral flap, 21
Dry-eye syndrome
description, 48
effect on quality of life, 48
symptoms of, 48
See also dysfunctional-tear syndrome
DTS
See dysfunctional-tear syndrome
DV
See DisCoVisc
Dysfunctional-tear syndrome
description
effect on quality of life, 48
symptoms of, 48
See also dry-eye syndrome

E
ECD
See endothelial-cell density, 59
Endophthalmitis
bacterial
endogenous, 35
bleb-related
complication of glaucoma filtration, 66
incidence in trabeculectomy with 5FU, 67
complication
after implantation of glaucoma drainage devices,
18v in AGV implantation, 21
with triamcinolone use, 25
development of, with candedemia, 34
distinguished from blebitis, 68
endogenous
empirical treatment of, 35
Candida, 33
fungal
endogenous, 35
incidence in MMC-augmented filtering surgery, 67
occurence after filtering surgery, 68
risk of, with candidemia, 34
risk factors for, 68
Endothelial corneal damage due to
phacoemulsification, 6
Endothelial cell
density
in donor eyes stored in Optisol GS, 59
function of, 60
loss
with use of viscoelastics during
phacoemulsification, 7
Endothelial-cell density
changes during storage in Optisol GS, 61
indicator of corneal viability, 60
Endothelium
corneal
effect of viscoelastics on, 5
Exfoliation syndrome
incidence among the Aeta, 44
Eye drops
effect on posterior-lid-margin sign in patients with
narrow occludable angles, 47, 51
F
Fluconazole
treatment for candidemia, 35

G
GDD
See glaucoma drainage devices, 18
Glaucoma
associated risk factors, 28
causes of, 3
compared with cataract, 3
cases among the Aeta population, 46
cause of blindness, 53
filtering surgery
use of 5-fluorouracil and mitomycin C in, 67
primary angle-closure
incidence among the Aeta, 41
prevalence in southeast Asia, 53
primary open-angle
incidence among the Aeta, 41, 44
public-health problem, 3
treated using drainage devices, 18
treatment of, 3
Glaucoma drainage devices
role in the treatment of glaucoma, 18

H
Higher-order aberration
in cataract, 10

I
Infection
bleb-related
complications of glaucoma filtration surgery, 69
diagnosis of, 69
treatment of, 69
Inflammation
postoperative
control of, 23
post-cataract surgery
control of, 22
relation to pain during surgery, 15
Intraocular lens
aspheric, 10
IQ, 10
implantation in cataract surgery, 10
Intraocular lenses
aspheric
comparison in the quality of vision and spherical
aberration, 9
Intraocular pressure
effect of massage lying down on, 27
effect of postural changes on, 28
elevated
factors associated with, 28
IOL
See intraocular lens, 10
IOP
See intraocular pressure, 27
Iridocorneal angle, 54
Iris thickness, 54, 58

K
Keratitis
complication of rosacea, 32

L
Laser peripheral iridotomy
standard treatment for angle closure, 53
in narrow occludable angles
ultrasound biomicroscopy outcomes after, 52, 57
LCD
See limbal-chamber depth, 54
Lid wiper
function, 48
Limbal-chamber depth, 53
grade, before and after LPI in eyes with NOA, 54, 56,
57
Liwan Eye Study, 58
Low vision
prevalence among the Aeta, 45
LPI
See laser peripheral iridotomy, 52
Lubricant
use in the management of dry-eye syndrome, 50
Lubrication
problem in patients with dry-eye syndrome, 48

M
Massage
face-down
effect on intraocular pressure in normal eyes, 27,
28
Meibomian gland
inflammation
contributing factor to rosacea, 32
Metronidazole
therapy for rosacea, 32

N
Narrow occludable angles
in females and older age groups, 57
ultrasound biomicroscopy outcomes after LPI, 52
Nasolacrimal-duct obstruction
as risk factor for the development of bleb-related
endophthalmitis, 68
NOA
See narrow occludable angles, 52

O
Ophthalmic education, 70
curiculum, 77
development of core competencies in, 77
surgical training, 79
Ophthalmic services
regional distribution of, 72
Ophthalmic viscoelastic devices
classifications of, 6
cohesive, properties of, 6
dispersive, properties of, 6
Ophthalmic-residency education
development in the Philippines, 71
Ophthalmology
residency training, 70
problems and challenges, 75
solutions to problems, 75
training in, 39
training centers
accreditation of, 73
distribution of, 73
Optic neuropathy
cause of blindness among the Aeta,
OVD
See ophthalmic viscoelastic devices

P
PACG
See glaucoma, primary angle-closure
Pain
in ocular surgery, 14
intra- and postoperative
with use of diclofenac, 15
PBO
See Philippine Board of Ophthalmology, 71
Penetrating keratoplasty
treatment for corneal opacity, 60
Phacoemulsification
corneal endothelial damage due to, 6
controlling inflammation in, 23
effect of viscoelastics after, 5
Philippine Academy of Ophthalmology, 39
programs in ophthalmology training, 75
Philippine Board of Ophthalmology, 39
achievements of, 71
guidelines for accreditation of ophthalmologists, 72
issues faced by, 71
training requirements and curriculum, 39
programs in ophthamlmology training, 76
Philippine Glaucoma Society, 3, 4
Piroxicam
use in laparoscopic surgery, 16
PKP
penetrating keratoplasty, 60
PLM
See posterior-lid margin, 47
Posterior- lid-margin
sign
correlation with dry-eye symptoms, 51
effect of lubricating eye drops on, 47
grading in DES patients treated with eye drop, 50
Prednisolone
safety and efficacy in postcataract inflammation, 22
Primary angle-closure glaucoma
resulting from primary angle-closure suspects, 53
Primary angle-closure suspects
progression to primary angle-closure glaucoma, 53
Pterygium
surgery
use of diclofenac as preemptive analgesic, 13

R
Refractive error
cause of blindness among the Aeta, 43
cause of low-vision among the Aeta, 45
Residency training
in ophthalmology, 39, 40
Retinochoroiditis
juxtapapillary toxoplasmic
treated with intravitreal clindamycin and
dexamethasone, 63, 64
toxoplasmic
presentation, 64
Rofecoxib
used in arthroscopic knee surgery, 16
Rosacea
case of, 30
characteristics of, 31
complications, 32
contributing factors, 31
diagnosis of, 31
differential diagnosis, 31
etiology, 31
incidence, 31
presentation, 31
treatment of, 32

S
Shaffer angle grade
before and after LPI in eyeswith NOA, 56-57
Spherical aberration
in eyes with and without cataract, 10
Steroids
intraocular delivery, 25
topical
postoperative use to control inflammation, 25
Streptococcus
cause of bleb infections, 68

T
Tetracycline
treatment for rosacea, 32
Toxoplasmosis
cause of posterior uveitis, 64
classical treatment for, 64
Trabeculectomy
bleb-related complications in, 67, 69
Transconjunctival erosion
factors that contribute to, 20
Trauma
cause of blindness among the Aeta, 43
Triamcinolone
complications in the use of, 23
intracameral
administration during surgery, 23
compared with steroids in controlling
inflammation, 25
complications, 25
safety and efficacy in postcataract inflammation, 22
use in controlling postoperative inflammation, 23,
25
Tube erosion
occurence in AGV implantation, 20
with donor scleral graft, 19
with autologous scleral flap, 19

U
UBM
See ultrasound biomicroscopy, 52
Ultrasound biomicroscopy
outcomes after LPI in eyes with NOA, 52, 57
use in imaging anterior-chamber-angle anatomy after
LPI, 53

V
Valsalva’s maneuver
link with IOP, 28
Vancomycin
for treatment of bleb-related endophthalmitis, 69
Viscoelastic
description of ideal, 7
role in anterior chamber, corneal endothelium, 6
Visual impairment
among the Aeta population, 41
worldwide prevalence, 45
prevalence among the Aeta, 45
Vitrectomy
use in treatment of Candida endophthalmitis, 35

W
World Glaucoma Association, 3-4

Author index to volume 33

Allingham, R. R., 41
Ang, R. T., 8
Babao, R. T., 13
Bulosan, T. R., 13
Caguioa, J. B., 9
Co, G. N., 22
Concepcion, M. E. T., 59
Coronel, M. C. G., 22
De Venecia III, A. B. F., 66
Dizon, B., 41
Dy Liacco, J. U., 30
Eclarinal, J. J., 41
Francia, P., 41
Galias, A. F., 13
Jacob, K. D., 30
Khu, P. M., 3, 52
Lat-Luna, M., 52, 66
League, J. E. E., 27
Leuenberger, E., 17, 27, 40
Lim Bon Siong, R., 47, 66
Lim, A. K. E., 33
Lim, J. A. H., 47
Lingao, M. D., 5
Martinez, G. A., 9
Martinez, J. M., 39
Martires, M. M., 59
Navarro, B., 41
Ong, Y. M., 33
Ongkeko-Perez, J., 17, 40
Padilla, M. D. B., 59
Quilendrino, M. R. M., 52
Reyes, K. B., 9
Reyno, D. Q., 13
Rivera, J. A., 17, 27, 40
Rivera-Francia, M. K., 41
Rodriguez, A. N., 13
Santiago-Turla, C., 41
Santos, E. M. G., 63
Sibayan, S. A. B., 59
Stinnet, S., 41
Tan, S. K., 33
Tuaño, P. M. C., 70
Uy, H. S., 5
Yap-Veloso, M. A., 17, 40

Reviewers, 2008

Abaño, Jessica Marie R.
Agahan, Archimedes D.
Alberto, Carlos S.
Ang, Robert Edward T.
Castillo, Teresita R.
Cloma, Lee Allen D.
Cruz, Fay Charmaine S.
Cruz, Raul T.
De Leon, Alejandro S.
De Leon, John Mark S.
Dualan, Ivo John S.
Dy-Liacco, Jacinto U.
Florcruz, Nilo Vincent D.G
Flores, John Vincent Policarpio G.
Flores, Kristine Margaret B.
Germar, Gregory Francis G.
Kho, Richard C.
Khu, Patricia M.
King, Jacqueline H.
Kleiner, Franklin P.
Leuenberger, Edgar U.
Lim Bon Siong, Ruben
Luna, Ma. Margarita L.
Mangubat, Leonardo R.
Marin, Jesus David F.
Martinez Jr., Jose Ma. G.
Naval, Carlos G.
Nepomuceno, Richard Raymund L.
Reyes, Johann Micheal G.
Roque, Manolette R.
Servera, Maria Rebecca A.
Sibayan, Santiago Antonio B.
Sua, Alex S.
Suntay, Analyn T.
Sy, Jocelyn L.
Tan, Alexander D.
Tumbocon, Joseph Anthony J.
Uy, Harvey S.
Valbuena, Marissa N.
Yan, Mary Rose P.
Yu, Annalisa T.
Yu-Keh, Ellen N.